Active components of AM can inhibit the progression of GC by affecting Akt phosphorylation, downregulating Akt kinase, and then regulating PI3K-Akt signal pathway to inhibit epithelial-mesenchymal transformation of GC [61]. Here, AKT1 is linked to gastric cancer.